Concepedia

A year-long extended release nanoformulated cabotegravir prodrug

Tanmay A. Kulkarni, Aditya N. Bade, Brady Sillman, Bhagya Laxmi Dyavar Shetty, Melinda Wojtkiewicz, Nagsen Gautam, James R. Hilaire, Sruthi Sravanam, Adam M. Szlachetka, Benjamin G. Lamberty,

Nature Materials · 2020 · 110 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Adherence to Medication

Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine · 2005 · 7.9K citations

, , +14

Ending the HIV Epidemic

Anthony S. Fauci, Robert Redfield, George Sigounas et al. · JAMA · 2019 · 1.5K citations · Full text

, , +12

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Susan Swindells, Jaime Andrade‐Villanueva, Gary Richmond et al. · New England Journal of Medicine · 2020 · 565 citations · Full text

, , +17

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink et al. · The Lancet · 2017 · 504 citations

, , +14

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 464 citations · Full text

, , +14